1,500
Views
19
CrossRef citations to date
0
Altmetric
Research Paper

Decreased expression of ALDH5A1 predicts prognosis in patients with ovarian cancer

, , , , , , , , , , & show all
Pages 245-251 | Received 15 Dec 2016, Accepted 09 Feb 2017, Published online: 27 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tao Shen, Haiyang Wang, Bin Tang, Guoping Zhu & Xiangting Wang. (2023) The impact of RNA binding proteins and the associated long non-coding RNAs in the TCA cycle on cancer pathogenesis. RNA Biology 20:1, pages 223-234.
Read now

Articles from other publishers (18)

Yu Chen & Xin Li. (2024) Aldehyde Dehydrogenases as Promising Targets for Treating Toxic Aldehyde-related Diseases. Current Medicinal Chemistry 31:8, pages 970-994.
Crossref
Vasileios Xanthis, Theodora Mantso, Anna Dimtsi, Aglaia Pappa & Vasiliki E. Fadouloglou. (2023) Human Aldehyde Dehydrogenases: A Superfamily of Similar Yet Different Proteins Highly Related to Cancer. Cancers 15:17, pages 4419.
Crossref
Jun Qiu, Haoyun Wang, Xin Lv, Lipeng Mao, Junyan Huang, Tao Hao, Junliang Li, Shuo Qi, Guodong Chen & Haiping Jiang. (2023) Hepatocellular carcinoma cell differentiation trajectory predicts immunotherapy, potential therapeutic drugs, and prognosis of patients. Open Life Sciences 18:1.
Crossref
Christina Piperi, Mirca S. Saurty-Seerunghen, Georgia Levidou, Athanasia Sepsa, Eleni-Andriana Trigka, Alexia Klonou, Mariam Markouli, Dimitrios Strepkos, Anastasia Spyropoulou, Dimitrios S. Kanakoglou, Eleftheria Lakiotaki, Eleni A. Karatrasoglou, Efstathios Boviatsis, Elias A. El-Habr & Penelope Korkolopoulou. (2023) Glioma Cells Expressing High Levels of ALDH5A1 Exhibit Enhanced Migration Transcriptional Signature in Patient Tumors. Neurotherapeutics 20:3, pages 881-895.
Crossref
Jie Xia, Siqin Li, Suling Liu & Lixing Zhang. (2023) Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets. MedComm 4:1.
Crossref
Emily R. Penick, Nicholas W. Bateman, Christine Rojas, Cuauhtemoc Magana, Kelly Conrads, Ming Zhou, Brian L. Hood, Guisong Wang, Niyati Parikh, Ying Huang, Kathleen M. Darcy, Yovanni Casablanca, Paulette Mhawech-Fauceglia, Thomas P. Conrads & G. Larry Maxwell. (2022) Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues. Clinical Proteomics 19:1.
Crossref
Cissy Zhang, Addison Quinones & Anne Le. (2022) Metabolic reservoir cycles in cancer. Seminars in Cancer Biology 86, pages 180-188.
Crossref
Senbang Yao, Wenjun Chen, He Zuo, Ziran Bi, Xiuqing Zhang, Lulian Pang, Yanyan Jing, Xiangxiang Yin & Huaidong Cheng. (2021) Comprehensive Analysis of Aldehyde Dehydrogenases (ALDHs) and Its Significant Role in Hepatocellular Carcinoma. Biochemical Genetics 60:4, pages 1274-1297.
Crossref
Lei Xia, Hairong Zhang, Xuezhen Wang, Xiaoyu Zhang & Ke Nie. (2021) The Role of Succinic Acid Metabolism in Ovarian Cancer. Frontiers in Oncology 11.
Crossref
Yue Qi, Mengyu Xin, Yuanfu Zhang, Yangyang Hao, Qian Liu, Peng Wang & Qiuyan Guo. (2021) TTSurv: Exploring the Multi-Gene Prognosis in Thousands of Tumors. Frontiers in Oncology 11.
Crossref
De-Zhen Guo, Ao Huang, Yu-Peng Wang, Ya Cao, Jia Fan, Xin-Rong Yang & Jian Zhou. (2021) Development of an Eight-gene Prognostic Model for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Xing‐Yan Deng, Xiao‐Xiong Gan, Jian‐Hua Feng, Wen‐Song Cai, Xin‐Quan Wang, Liang Shen, Hong‐Tu Luo, Zhen Chen, Mengli Guo, Jie Cao, Fei Shen & Bo Xu. (2020) ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma . Cell Biochemistry and Function 39:2, pages 317-325.
Crossref
Congyuan Zhu, Hao Hu, Jianping Li, Jingli Wang, Ke Wang & Jingqiu Sun. (2020) Identification of key differentially expressed genes and gene mutations in breast ductal carcinoma in situ using RNA-seq analysis. World Journal of Surgical Oncology 18:1.
Crossref
Xubing Wang, Yanjie Zhao, Jiao Luo, Lin Xu, Xinmei Li, Yuan Jin, Chuanhai Li, Meiyao Feng, Ying Wang, Jing Chen, Yufei Hou, Qianwen Zhao, Jinquan Zhao, Baitang Ning, Yuxin Zheng & Dianke Yu. (2020) MicroRNA hsa-miR-1301-3p Regulates Human ADH6 , ALDH5A1 and ALDH8A1 in the Ethanol-Acetaldehyde-Acetate Metabolic Pathway . Molecular Pharmacology 98:2, pages 120-129.
Crossref
Jolanta Pamuła-Piłat, Karolina Tęcza, Magdalena Kalinowska-Herok & Ewa Grzybowska. (2020) Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients. Scientific Reports 10:1.
Crossref
Saketh S. Dinavahi, Christopher G. Bazewicz, Raghavendra Gowda & Gavin P. Robertson. (2019) Aldehyde Dehydrogenase Inhibitors for Cancer Therapeutics. Trends in Pharmacological Sciences 40:10, pages 774-789.
Crossref
Menghuang Zhao, Miaomiao Ye, Junhan Zhou & Xueqiong Zhu. (2019) Prognostic values of transketolase family genes in ovarian cancer. Oncology Letters.
Crossref
Zhendong Liu, Haigang Chang, Xingbo Cheng, Qingnan Wang, Rongjun Qian & Yanzheng Gao. (2022) Potential Value of Expression of Receptor Accessory Protein 4 in  Lower - Grade Glioma For Antitumor Immunotherapy. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.